Healthcare
Thursday, March 31, 2016
BRIEF-Selvita signs another deal with Merck KGaA
* Signs another deal with Merck KGaA for the development and commercialization of oncological terapeutical molecules developed by Selvita as a part of its cancer metabolism platform
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment